20.02.2024 • News

Equinor Signs 15-Year LNG Supply Deal with Deepak

Norwegian energy group Equinor and India’s Deepak Fertilisers and Petrochemicals Corporation (DFPCL) have signed a 15-year contract for the supply of liquefied natural gas (LNG), scheduled to start in 2026.

Equinor said that it will supply LNG from its plant in Hammerfest, Norway and LNG sourced mainly from the US.

Deepak wants to use the gas mainly as feedstock for production of ammonia in its newly commissioned plant for manufacturing fertilizers and petrochemicals. The agreement covers a supply of around 0.65 million t/y (ca 9 TWh) of LNG.

“Deepak’s new ammonia plant has created new gas demand in the growing Indian market. I am very happy that we have landed this agreement with Deepak Fertilisers. The agreement is another proof of how we use our position in the Atlantic basin to strengthen our relationship with key players in the growing Indian market. We look forward to developing our relationship with Deepak and to exploring avenues for further collaboration on petrochemicals feedstocks such as propane and ethane and on low carbon ammonia in the future”, said Helge Haugane, Equinor’s senior vice president for Gas & Power.

Sailesh C. Mehta, chairman and managing director of DFPCL, added: “We are very happy to enter into this long-term agreement with Equinor for supply of LNG. The agreement will provide reliable supplies of feedstock which will further strengthen Deepak Fertilisers’ value-chain from gas to ammonia, the key ingredient in fertilizers. The agreement will help us absorb global volatility as well as enhance overall margins. We also look forward to exploring with Equinor further collaboration on feedstock and carbon footprint reduction initiatives.”

Ole Jørgen Bratland/©Equinor
Ole Jørgen Bratland/©Equinor

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.